Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway

Cancer Letters

Volumn 361, Issue 1, 2015, Pages 67-74

  Duan, Yumei ^a   Li, Zhi ^a   Cheng, Shiyue ^a   Chen, Yan ^a   Zhang, Lu ^a   He, Jiang ^a   Liao, Qiong ^a   Yang, Lifang ^a   Gong, Zhicheng ^a   Sun, Lun Quan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

EBV encoded non coding RNAs (EBERs); Inflammation; Nasopharyngeal carcinoma (NPC); Retinoic acid inducible gene I (RIG I)

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; EBV ENCODED NON CODING RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; AUTACOID; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; EPSTEIN-BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 2; INTERFERON REGULATORY FACTOR 3; IRF3 PROTEIN, HUMAN; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CARCINOMA CELL; CYTOKINE RELEASE; FEMALE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; COCULTURE; DISEASE COURSE; DRUG SCREENING; ENZYME IMMUNOASSAY; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; MACROPHAGE; METABOLISM; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

HUMAN HERPESVIRUS 4;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; DEAD-BOX RNA HELICASES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON REGULATORY FACTOR-3; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, VIRAL; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925270208     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.037     Document Type: Article

References (55)

1. Saha A., Kaul R., Murakami M., Robertson E.S. Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention. Cancer Biol. Ther 2010, 10:961-978.
2. White M.K., Pagano J.S., Khalili K. Viruses and human cancers: a long road of discovery of molecular paradigms. Clin. Microbiol. Rev 2014, 27:463-481.
3. Chugh P.E., Sin S.H., Ozgur S., Henry D.H., Menezes P., Griffith J., et al. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog 2013, 9:e1003484.
4. Iwakiri D., Takada K. Role of EBERs in the pathogenesis of EBV infection. Adv. Cancer Res 2010, 107:119-136.
5. Jiang Y., Li Y., Fang S., Jiang B., Qin C., Xie P., et al. The role of MALAT1 correlates with HPV in cervical cancer. Oncol. Lett 2014, 7:2135-2141.
6. Liu Y., Pan S., Liu L., Zhai X., Liu J., Wen J., et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS ONE 2012, 7:e35145.
7. Nana-Sinkam S.P., Croce C.M. Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol. Oncol 2011, 5:483-491.
8. Tomita M., Tanaka Y., Mori N. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int. J. Cancer 2012, 130:2300-2309.
9. Xie H., Lee L., Caramuta S., Hoog A., Browaldh N., Bjornhagen V., et al. MicroRNA expression patterns related to merkel cell polyomavirus infection in human Merkel cell carcinoma. J. Invest. Dermatol 2014, 134:507-517.
10. Samanta M., Iwakiri D., Kanda T., Imaizumi T., Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 2006, 25:4207-4214.
11. Lerner M.R., Andrews N.C., Miller G., Steitz J.A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:805-809.
12. Toczyski D.P., Steitz J.A. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J. 1991, 10:459-466.
13. Clarke P.A., Schwemmle M., Schickinger J., Hilse K., Clemens M.J. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991, 19:243-248.
14. Yamamoto N., Takizawa T., Iwanaga Y., Shimizu N. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett 2000, 484:153-158.
15. Swaminathan S., Tomkinson B., Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:1546-1550.
16. Ramos H.J., Gale M. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr. Opin. Virol 2011, 1:167-176.
17. Onoguchi K., Yoneyama M., Fujita T. Retinoic acid-inducible gene-I-like receptors. J. Interferon Cytokine Res 2011, 31:27-31.
18. Kubler K., Gehrke N., Riemann S., Bohnert V., Zillinger T., Hartmann E., et al. Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells. Cancer Res 2010, 70:5293-5304.
19. Hou J., Zhou Y., Zheng Y., Fan J., Zhou W., Ng I.O., et al. Hepatic RIG-I predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma. Cancer Cell 2014, 25:49-63.
20. Samanta M., Iwakiri D., Kanda T., Imaizumi T., Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 2006, 25:4207-4214.
21. Rickinson A. Epstein-Barr virus. Virus Res 2002, 82:109-113.
22. Yoneyama M., Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev 2009, 227:54-65.
23. Loo Y.M., Gale M. Immune signaling by RIG-I-like receptors. Immunity 2011, 34:680-692.
24. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med 2008, 205:1601-1610.
25. Banerjee A.S., Pal A.D., Banerjee S. Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration. Viology 2013, 443:294-305.
26. Cheung S.T., Huang D.P., Hui A.B., Lo K.W., Ko C.W., Tsang Y.S., et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 1999, 83:121-126.
27. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
28. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
29. Schmidt A., Rothenfusser S., Hopfner K.P. Sensing of viral nucleic acids by RIG-I: from translocation to translation. Eur. J. Cell Biol 2012, 91:78-85.
30. Deschenes-Simard X., Kottakis F., Meloche S., Ferbeyre G. ERKs in cancer: friends or foes?. Cancer Res 2014, 74:412-419.
31. Koul H.K., Pal M., Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 2013, 4:342-359.
32. Roberts P.J., Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26:3291-3310.
33. Kuroda T., Kitadai Y., Tanaka S., Yang X., Mukaida N., Yoshihara M., et al. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin. Cancer Res 2005, 11:7629-7636.
34. Cheon H., Borden E.C., Stark G.R. Interferons and their stimulated genes in the tumor microenvironment. Semin. Oncol 2014, 41:156-173.
35. Landskron G., De la Fuente M., Thuwajit P., Thuwajit C., Hermoso M.A. Chronic inflammation and cytokines in the tumor microenvironment. J. Immunol. Res 2014, 2014:149-185.
36. Varney M.L., Olsen K.J., Mosley R.L., Bucana C.D., Talmadge J.E., Singh R.K. Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 2002, 16:471-477.
37. Varney M.L., Olsen K.J., Mosley R.L., Singh R.K. Paracrine regulation of vascular endothelial growth factor-a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J. Interferon Cytokine Res 2005, 25:674-683.
38. Glickman J.N., Howe J.G., Steitz J.A. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol 1988, 62:902-911.
39. Wu Y., Maruo S., Yajima M., Kanda T., Takada K. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J. Virol 2007, 81:11236-11245.
40. Komano J., Maruo S., Kurozumi K., Oda T., Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J. Virol 1999, 73:9827-9831.
41. Samanta M., Iwakiri D., Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008, 27:4150-4160.
42. Iwakiri D., Sheen T.S., Chen J.Y., Huang D.P., Takada K. Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 2005, 24:1767-1773.
43. Iwakiri D., Eizuru Y., Tokunaga M., Takada K. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res 2003, 63:7062-7067.
44. Hussain S.P., Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 2007, 121:2373-2380.
45. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest 2007, 117:1175-1183.
46. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
47. Elinav E., Nowarski R., Thaiss C.A., Hu B., Jin C., Flavell R.A. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 2013, 13:759-771.
48. Rimessi A., Patergnani S., Ioannidi E., Pinton P. Chemoresistance and cancer-related inflammation: two hallmarks of cancer connected by an atypical link, PKCzeta. Front. Oncol 2013, 3:232.
49. Laine A., Iyengar P., Pandita T.K. The role of inflammatory pathways in cancer-associated cachexia and radiation resistance. Mol. Cancer Res 2013, 11:967-972.
50. Wong H.L., Wang X., Chang R.C., Jin D.Y., Feng H., Wang Q., et al. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol. Carcinog 2005, 44:92-101.
51. Banerjee A.S., Pal A.D., Banerjee S. Epstein-Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration. Virology 2013, 443:294-305.
52. Lopez-Novoa J.M., Nieto M.A. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol. Med 2009, 1:303-314.
53. Ye Y., Liu P., Wang Y., Li H., Wei F., Cheng Y., et al. Neurotensin, a novel messenger to cross-link inflammation and tumor invasion via epithelial-mesenchymal transition pathway. Int. Rev. Immunol 2014, Epub ahead of print.
54. Shigdar S., Li Y., Bhattacharya S., O'Connor M., Pu C., Lin J., et al. Inflammation and cancer stem cells. Cancer Lett 2014, 345:271-278.
55. Quante M., Wang T.C. Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology (Bethesda) 2008, 23:350-359.